fda bpc-157 statement panel backs compounded BPC-157, KPV peptides in win for RFK Jr An FDA panel will consider

An FDA panel will consider whether to allow compounding pharmacies to manufacture certain peptides. Here's what to know about their safety and efficacy. An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures FDA reviews BPC 157, TB 500 and other peptides favored by RFK Jr. AP News

SKU: 54717160100 · From cantondelareina.com.ar